Intratumoral heterogeneity refers to the existence of diverse subpopulations of cancer cells within a single tumor, contributing to variations in genetic, phenotypic, and behavioral traits. This heterogeneity poses significant challenges for effective treatment, as different subpopulations may respond differently to therapies, leading to drug resistance and disease progression.